Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
559 Armoring logic-gated CAR T cells with a membrane-tethered IL-12 booster: initial data from the EVEREST-2 study of A2B543 in advanced solid tumors
21 affiliations
- 1A2 Biotherapeutics, Inc., Agoura Hills, CA, USA
- 2Department of Obstetrics & Gynecology, Stanford University, Palo Alto, California, USA
- 3Mayo Clinic, Jacksonville, FL, USA
- 47Vanderbilt University, Nashville, TN, USA
- 5Critical Care Department, University College Hospital, London, UK
- 63H. Lee Moffitt Cancer Center, Tampa, FL, USA
- 7Moffitt Cancer Center, Tampa, Florida, USA
- 8Mayo Clinic, Rochester, MN, USA
- 93UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA
- 105Mayo Clinic, Rochester, MN, USA
- 118University of California San Diego Health, San Diego, CA, USA
- 12Banner MD Anderson Cancer Center, Gilbert, AZ, USA
- 132UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA
- 14Fred Hutchinson Cancer Center, Seattle, WA, USA
- 15University of California San Diego Moores Cancer Center, San Diego, CA, USA
- 16H. Lee Moffitt Cancer Center, Tampa, FL, USA
- 17Massachusetts General Hospital, Charlestown, MA, USA
- 18The Ohio State University James Comprehensive Cancer Center, Columbus, OH, USA
- 19Vanderbilt University, Nashville, TN, USA
- 20New York University, New York, NY, USA
- 21Washington University School of Medicine, Saint Louis, MO, USA
Related
- Combining an autoactivated cGAS mutant with membrane-tethered IL-12 via mRNA lipid nanoparticles promotes systemic tumor control
- Gallium-68 (68Ga)-Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Initial Staging of High-Risk Prostatic Adenocarcinoma: Reclassification to Oligometastatic Disease and Change in Treatment Intent
- Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series
- Extracellular matrix–targeted TNC-scFv armoring enhances CAR T cell persistence and antitumor activity in solid tumors
- Rare Sites of Metastases to the Breast and Integumentary System in Advanced Cervical Cancer at Initial Presentation in Eastern Uganda: A Case Report.
BibTeX
@article{mardiros2026armoring,
title = {{559 Armoring logic-gated CAR T cells with a membrane-tethered IL-12 booster: initial data from the EVEREST-2 study of A2B543 in advanced solid tumors}},
author = {Armen Mardiros and Oliver Dorigo and Yanyan Lou and Cathy Eng and John Welch and Monica Avila and Kedar Kirtane and Julian Molina and J Randolph Hecht and Antonious Hazim and Peter Vu and Matthew Ulrickson and Jasmine Mitchell and Jennifer M Specht and Sandip P Patel and Frederick L Locke and Marcela V Maus and Jinesh S Gheeya and Kristen K Ciombor and Eric W Ng and Salman R Punekar and Jeffrey P Ward and David B Zhen and David G Maloney and Zachary Yeung and Theodore H Welling and Rosalyn I Marar and Jacqueline D Xuan},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0559},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0559},
note = {CC BY},
}
RIS
TY - JOUR
TI - 559 Armoring logic-gated CAR T cells with a membrane-tethered IL-12 booster: initial data from the EVEREST-2 study of A2B543 in advanced solid tumors
AU - Armen Mardiros
AU - Oliver Dorigo
AU - Yanyan Lou
AU - Cathy Eng
AU - John Welch
AU - Monica Avila
AU - Kedar Kirtane
AU - Julian Molina
AU - J Randolph Hecht
AU - Antonious Hazim
AU - Peter Vu
AU - Matthew Ulrickson
AU - Jasmine Mitchell
AU - Jennifer M Specht
AU - Sandip P Patel
AU - Frederick L Locke
AU - Marcela V Maus
AU - Jinesh S Gheeya
AU - Kristen K Ciombor
AU - Eric W Ng
AU - Salman R Punekar
AU - Jeffrey P Ward
AU - David B Zhen
AU - David G Maloney
AU - Zachary Yeung
AU - Theodore H Welling
AU - Rosalyn I Marar
AU - Jacqueline D Xuan
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0559
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0559
SN - 2051-1426
ER -